ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023

InvestorPlace – Stock Market News, Stock Advice & Trading Tips

ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

The post ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023 appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• “America’s Top Trader” Issues A.I. Code Red: Act Now or Miss Out
• It doesn’t matter if you have $500 or $5 million. Do this now.